Stockscreener 앱 받기
0.8307
3.62%
-0.0312
시간 외 거래:
.84
0.0093
+1.12%
전일 마감가:
$0.8619
열려 있는:
$0.852
하루 거래량:
642.51K
Relative Volume:
0.85
시가총액:
$79.31M
수익:
$169.43M
순이익/손실:
$-186.01M
주가수익비율:
-0.4112
EPS:
-2.02
순현금흐름:
$70.07M
1주 성능:
-2.28%
1개월 성능:
-10.98%
6개월 성능:
-48.08%
1년 성능:
-9.52%
1일 변동 폭
$0.818
$0.8625
1주일 범위
$0.818
$0.9391
52주 변동 폭
$0.7324
$1.798
애서티오 홀딩스 Stock (ASRT) Company Profile
명칭
Assertio Holdings Inc
전화
(224) 419-7106
주소
100 S. SAUNDERS ROAD, LAKE FOREST, IL
ASRT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
0.8307 | 79.31M | 169.43M | -186.01M | 70.07M | -2.02 |
|
ZTS
Zoetis Inc
|
165.02 | 74.45B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.49 | 42.91B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.24 | 41.98B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.49 | 24.35B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
11.96 | 14.28B | 15.05B | -883.30M | 1.89B | -0.74 |
애서티오 홀딩스 Stock (ASRT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-26 | 개시 | Maxim Group | Buy |
| 2024-07-03 | 개시 | H.C. Wainwright | Buy |
| 2022-11-07 | 개시 | Lake Street | Buy |
| 2018-11-30 | 다운그레이드 | Mizuho | Buy → Neutral |
애서티오 홀딩스 주식(ASRT)의 최신 뉴스
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Assertio Holdings Names New Chief Commercial Officer, Awards Major Stock Incentive Package - StockTitan
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Assertio Holdings, Inc. - AccessWire
Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Up 14.1% in December - MarketBeat
Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment? - Simply Wall St
Assertio appoints new independent director to board By Investing.com - Investing.com South Africa
Assertio appoints new independent director to board - Investing.com
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors - The Manila Times
Assertio Holdings Taps Former Astellas President Who Led $5B Sales Growth to Join Board - StockTitan
Assertio’s (ASRT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Assertio Therapeutics shares get buy rating on clinical trial results By Investing.com - Investing.com Canada
Assertio (NASDAQ:ASRT) Receives Buy Rating from HC Wainwright - MarketBeat
Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Down 11.5% in November - MarketBeat
Assertio reports positive Rolvedon trial results for breast cancer By Investing.com - Investing.com Australia
Assertio Announces Results of Rolvedon (Eflapegrastim-Xnst) Injection Same-Day Dosing Clinical Study - Marketscreener.com
Assertio reports positive Rolvedon trial results for breast cancer - Investing.com
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study - The Manila Times
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO - The Manila Times
Assertio Holdings Creates Transformation Office, Appoints New Leadership to Drive Growth Strategy - StockTitan
Assertio Holdings Inc (NASDAQ: ASRT): Blank Check On Growth? - Stocks Register
Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer - GlobeNewswire Inc.
Beam Therapeutics names Sravan K. Emany as new CFO - Investing.com
HC Wainwright Forecasts Stronger Earnings for Assertio - MarketBeat
Assertio shares hold price target, buy rating on stable Indocin share By Investing.com - Investing.com Canada
Assertio Holdings, Inc. (NASDAQ:ASRT) Shares Acquired by Empowered Funds LLC - Defense World
Assertio Holdings Q3 2024 Earnings Preview - MSN
Assertio stock gains amid Q3 earnings, clash with activist investor - MSN
Insider Buying: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Acquires $60,000.00 in Stock - MarketBeat
Assertio Holdings director Heather Mason buys $60,000 in shares By Investing.com - Investing.com Nigeria
Assertio Holdings director Heather Mason buys $60,000 in shares - Investing.com
Assertio Holdings CEO Brendan O'Grady buys $9,950 in common stock - Investing.com India
Spectrum Pharma Faces Senate Probe Call Over Alleged Rolvedon Data Fraud | ASRT Stock News - StockTitan
Assertio Holdings Inc (ASRT) Quarterly 10-Q Report - Quartz
Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2024 Earnings Call Transcript - Insider Monkey
Assertio Reports Third Quarter 2024 Financial Results - The Manila Times
Assertio: Q3 Earnings Snapshot - The Washington Post
Assertio Therapeutics’ Q3 2024 Earnings Overview - TipRanks
Assertio stock gains amid Q3 earnings, clash with activist investor (NASDAQ:ASRT) - Seeking Alpha
Assertio (ASRT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Assertio Holdings, Inc. Announces Board Changes - Marketscreener.com
Assertio Holdings Faces SEC Whistleblower Complaint Over Alleged Clinical Data Fraud | ASRT Stock News - StockTitan
Assertio Provides Response to Letter from Short-seller - GlobeNewswire
Assertio Holdings CEO Fires Back at Short-Seller's 'Baseless' Rolvedon Claims | ASRT Stock News - StockTitan
Assertio Holdings (NASDAQ:ASRT investor five-year losses grow to 72% as the stock sheds US$17m this past week - Simply Wall St
Assertio faces fraud claims, investor goes short on stock By Investing.com - Investing.com India
Assertio Stock Alert: Major Investor Warns of Fraud Claims, Safety Issues in Spectrum Deal | ASRT Stock News - StockTitan
Assertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
애서티오 홀딩스 (ASRT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.12%
0.89%
자본화:
|
볼륨(24시간):